Biovest International

About:

Biovest International develops fiber bioreactor systems and instruments to help achieve high cell densities.

Description:

Biovest International, Inc. is a publicly-traded (OTCQB: BVTI), emerging leader in the field of active personalized immunotherapy targeting life-threatening cancers of the blood system, and markets state-of-the-art hollow fiber bio-production instruments, as well as provides custom cell culture services, including contract manufacturing.

Total Funding Amount:

$7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Tampa, Florida, United States

Founded Date:

1981-01-01

Contact Email:

investorrelations(AT)biovest.com

Founders:

Christopher Kyriakides

Number of Employees:

11-50

Last Funding Date:

2010-10-28

IPO Status:

Private

Industries: